<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/100854">
      <dc:title>Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.</dc:title>
      <dc:creator>Callejas Rubio, José Luis</dc:creator>
      <dc:creator>López Pérez, Lourdes</dc:creator>
      <dc:creator>Ortego Centeno, Norberto</dc:creator>
      <dc:date>2025-01-29T07:30:05Z</dc:date>
      <dc:date>2025-01-29T07:30:05Z</dc:date>
      <dc:date>2008-12</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Callejas-Rubio JL, López-Pérez L, Ortego-Centeno N. Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis. Ther Clin Risk Manag. 2008 Dec;4(6):1305-13. doi: 10.2147/tcrm.s967. PMID: 19337437; PMCID: PMC2643111.</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/100854</dc:identifier>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:publisher>Ther Clin Risk Manag</dc:publisher>
   </ow:Publication>
</rdf:RDF>